Blood-Based CRC Test Upgrades Improve on Precancerous Lesion Detection Nancy A. Melville

https://www.medscape.com/viewarticle/blood-based-crc-test-upgrades-improve-precancerous-lesion-2026a10013i5?src= NASHVILLE, Tenn. — Updates to an FDA-approved colorectal cancer (CRC) blood test increased the detection of advanced precancerous lesions (APLs), a new study showed. “The updated test has improved performance, better detection of advanced precancerous lesions, resulting in larger projected reductions in CRC incidence and mortality at the population level,” said first author Aasma Shaukat, MD, MPH, of the NYU Grossman School of Medicine in New York City.